Form 4 for RGNX REGENXBIO Inc.
Accepted 2022-01-04 00:00:00 ET · period of report 2022-01-01 · accession 0001562180-22-000155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-04 | 2022-01-01 | RGNX | Christmas Patrick J. | CLO | F - Tax | $32.70 | -1,332 | 15.0K | -8% | -$43.6K |
| D | 2022-01-04 | 2022-01-03 | RGNX | Christmas Patrick J. | CLO | A - Grant | $0.00 | +7,900 | 22.9K | +53% | $0 |
| D | 2022-01-04 | 2022-01-03 | RGNX | Christmas Patrick J. | CLO | A - Grant | $0.00 | +37.4K | 37.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-01 | F | D | 1,332 | $32.70 | 15,040 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-03 | A | A | 7,900 | $0.00 | 22,940 | D | — | — | (F1) Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026 while the recipient provides continuous service to the Issuer. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-01-03 | A | A | 37,400 | $0.00 | 37,400 | D | $34.31 · — to 2032-01-03 | 37,400 Common Stock | (F2) 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2023 while the optionee provides continuous service to the Issuer. |